S-2HG增加中枢记忆CD8细胞并改善CAR-T疗效
该研究基于前期小鼠发现,在临床级人供者CAR-T细胞制备中,用免疫代谢物2-羟基戊二酸的S对映体(S-2HG)培养初始CD8前体,所得CAR-T细胞可在体内建立长期记忆,抗肿瘤反应优于标准方案,为B细胞恶性肿瘤的1期临床试验提供依据。
要点
- S-2HG处理可自初始前体生成临床级人CAR-T细胞。
- S-2HG处理的CAR-T细胞体内建立长期记忆并增强抗肿瘤反应。
- 结果为S-2HG处理CD19-CAR-T的1期临床试验提供依据。
核心结论
- S-2HG处理的临床级人供者CAR-T细胞可在体内建立长期记忆并显示优于标准方案的抗肿瘤反应。
研究设计与样本
- 基于人供者临床级CAR-T细胞的体外培养与体内功能评价研究。
主要发现
- S-2HG处理的CAR-T细胞可在体内建立长期记忆细胞。
- 与标准临床方案生成的CAR-T细胞相比,S-2HG处理组抗肿瘤反应更优。
- 临床级人供者CAR-T细胞可自初始前体经S-2HG培养生成。
临床怎么用
- 为评估S-2HG处理CD19-CAR-T细胞在B细胞恶性肿瘤患者中活性的1期临床试验提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cancer immunotherapy is advancing rapidly and gene-modified T cells expressing chimeric antigen receptors (CARs) show particular promise. A challenge of CAR-T cell therapy is that the ex vivo-generated CAR-T cells become exhausted during expansion in culture, and do not persist when transferred back to patients. It has become clear that naive and memory CD8 T cells perform better than the total CD8 T-cell populations in CAR-T immunotherapy because of better expansion, antitumor activity, and persistence, which are necessary features for therapeutic success and prevention of disease relapse. However, memory CAR-T cells are rarely used in the clinic due to generation challenges. We previously reported that mouse CD8 T cells cultured with the S enantiomer of the immunometabolite 2-hydroxyglutarate (S-2HG) exhibit enhanced antitumor activity. Here, we show that clinical-grade human donor CAR-T cells can be generated from naive precursors after culture with S-2HG. S-2HG-treated CAR-T cells establish long-term memory cells in vivo and show superior antitumor responses when compared with CAR-T cells generated with standard clinical protocols. This study provides the basis for a phase 1 clinical trial evaluating the activity of S-2HG-treated CD19-CAR-T cells in patients with B-cell malignancies.
引用
- Foskolou IP, Barbieri L, Vernet A, et al. The S enantiomer of 2-hydroxyglutarate increases central memory CD8 populations and improves CAR-T therapy outcome. Blood Adv. 2020. PMID: 32941648. doi:10.1182/bloodadvances.2020002309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。